Understanding convergent signaling regulation in metastatic breast cancer cells using a bioengineered stem cell microenvironment

Abstract

Aim: The convergence of tumorigenic and embryonic signaling pathways drives us to exploit the embryonic stem cell (ESC) microenvironment to restrict metastatic potential of cancer cells. We have previously demonstrated that bioengineered ESC microenvironments could restrict growth and metastatic potential of highly aggressive breast cancer cell (BCC). This study aims to further understand the regulation of convergent EGFR and canonical Wnt/β-catenin signaling pathway function in triple negative metastatic BCCs using the 3D in vitro ESC microenvironment created by encapsulating ESCs in alginate hydrogel microstrands.

Methods: Co-culture with ESC-microstrands increased sensitivity to two chemotherapeutic drugs in metastatic BCCs. To test whether these changes were due to restored signaling pathway regulation in BCCs, we probed for changes in gene expression of key molecules related to the EGFR and canonical Wnt/β-catenin signaling pathways using quantitative reverse transcription polymerase chain reaction and Western blot analysis.

Results: ESC-microstrands are able to alter the gene expression of highly aggressive BCCs at both mRNA and protein levels. These changes are indicative of a reversal of EGFR and canonical Wnt/β-catenin signaling pathway hyperactivation following co-culture. Increased NKD2 mRNA and protein expression coinciding with dual signaling pathway inhibition within co-cultured BCCs suggests that this reversal may be attributable to restored regulation of NKD2 within these pathways.

Conclusion: ESC-microstrands are able to reverse oncogenic signaling pathway hyperactivation and restore signaling pathway regulation in metastatic BCCs. Further studies could provide insight into what role NKD2 up-regulation plays in BCC inhibition, leading to the development of a new targeted therapy for metastatic breast cancer.

Keywords

Metastasis / cancer cell / signaling / 3D culture / stem cells / EGFR / Wnt/β-catenin / NKD2

References

[1] Lebert JM,Powell E,McCarthy J.Advances in the systemic treatment of triple-negative breast cancer..20182018;25:9 PMCID:PMC6001760

[2] Abbott DE,Postovit LM,Margaryan N.The epigenetic influence of tumor and embryonic microenvironments: how different are they?.Cancer Microenvironment2008;1:13-21 PMCID:PMC2654360

[3] Quail DF,Jewer M.Nodal signalling in embryogenesis and tumourigenesis..Int J Biochem Cell Biol2013;45:885-98

[4] Mooney BM,Li Y.Convergent mechanisms in pluripotent stem cells and cancer: implications for stem cell engineering..Biotechnol J2013;8:408-19

[5] Dong W,Shen H,Du J.Antitumor effect of embryonic stem cells in a non-small cell lung cancer model: antitumor factors and immune responses..Int J Med Sci2013;10:1314-20 PMCID:PMC3752719

[6] Zhang Z,Chang X,Li Y.Human embryonic stem cells--a potential vaccine for ovarian cancer..Asian Pac J Cancer Prev2012;13:4295-300

[7] Tzukerman M,Reiter I,Denkberg G.The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts..Cancer Res2006;66:3792-801

[8] Abdul Raof N,Xie Y.Bioengineering embryonic stem cell microenvironments for the study of breast cancer..Int J Mol Sci2011;12:7662-91 PMCID:PMC3233430

[9] Raof N,Castracane J.Bioengineering embryonic stem cell microenvironments for exploring inhibitory effects on metastatic breast cancer cells..Biomaterials2011;32:4130-9

[10] Mooney B,Tian YI.Restriction of cancer metastatic potential using embryonic stem cells encapsulated in alginate hydrogel microstrands..ACS Biomater Sci Eng2017;3:1769-79

[11] Scaltriti M.The epidermal growth factor receptor pathway: a model for targeted therapy..Clin Cancer Res2006;12:5268-72

[12] Sheeba CJ,Revina AM.Signaling pathways influencing tumor microenvironment and their exploitation for targeted drug delivery..Nanotechnol Rev2013;

[13] Merla A.Novel drugs targeting the epidermal growth factor receptor and its downstream pathways in the treatment of colorectal cancer: a systematic review..Chemother Res Pract2012;2012:11 PMCID:PMC3477664

[14] Lemmon MA.Cell signaling by receptor tyrosine kinases..Cell2010;141:1117-34 PMCID:PMC2914105

[15] Lu Y,Stewart TA.NSP1 defines a novel family of adaptor proteins linking integrin and tyrosine kinase receptors to the c-Jun N-terminal Kinase/Stress-activated protein kinase signaling pathway..J Biol Chem1999;274:10047-52

[16] Ahmad A.Pathways to breast cancer recurrence..ISRN Oncol2013;2013:16 PMCID:PMC3603357

[17] Clevers H.Wnt/β-catenin signaling in development and disease..Cell2006;127:469-80

[18] Clevers H.Wnt/β-catenin signaling and disease..Cell2012;149:1192-205

[19] Green JL,Yum KW,Rodewald LW.Paracrine Wnt signaling both promotes and inhibits human breast tumor growth..Proc Natl Acad Sci U S A2013;110:6991-6 PMCID:PMC3637696

[20] Gilles C,Mestdagt M,Ruggeri P.Transactivation of vimentin by β-catenin in human breast cancer cells..Cancer Res2003;63:2658-64

[21] Bremm A,Fuchs M,Duyster J.Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations..Cancer Res2008;68:707-14

[22] Lu Z,Wang Z.Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of β-catenin, and enhanced tumor cell invasion..Cancer Cell2003;4:499-515

[23] Nejak-Bowen KN.Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad..Semin Cancer Biol2011;21:44-58 PMCID:PMC3050081

[24] Wilding J,Soutter WP,Del Buono R.E-Cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes..Cancer Res1996;56:5285-92

[25] Lee EYHP.Oncogenes and tumor suppressor genes..Cold Spring Harb Perspect Biol2010;2:a003236 PMCID:PMC2944361

[26] Thiery JP.Complex networks orchestrate epithelial-mesenchymal transitions..Nat Rev Mol Cell Biol2006;7:131

[27] Normanno N,Bianco C,Mancino M.Epidermal growth factor receptor (EGFR) signaling in cancer..Gene2006;366:2-16

[28] Schlange T,Lienhard S,Hynes NE.Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation..Breast Cancer Res2007;9:R63 PMCID:PMC2242658

[29] Hu T.Convergence between Wnt-β-catenin and EGFR signaling in cancer..Molecular Cancer2010;9:236 PMCID:PMC2944186

[30] Yue X,Yang W,Han L.Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells..Brain Res2010;1366:27-37

[31] Rübsam M,Kubo A,Jüngst C.E-cadherin integrates mechanotransduction and EGFR signaling to control junctional tissue polarization and tight junction positioning..Nat Commun2017;8:1250 PMCID:PMC5665913

[32] Dong Y,Zhang M,Herman JG.Epigenetic silencing of NKD2, a major component of wnt signaling, promotes breast cancer growth..Oncotarget2015;6:22126-38 PMCID:PMC4673151

[33] Zhao S,Gao Y,Creighton CJ.NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma..Oncogene2015;34:5069 PMCID:PMC4802362

[34] Li C,Graves-Deal R,Cao Z.Myristoylated Naked2 escorts transforming growth factor α to the basolateral plasma membrane of polarized epithelial cells..Proc Natl Acad Sci U S A2004;101:5571-6 PMCID:PMC397424

[35] Zhou S,Arena V,Arena GO.Reprogramming malignant cancer cells toward a benign phenotype following exposure to human embryonic stem cell microenvironment..PLoS One2017;12:e0169899 PMCID:PMC5222525

[36] Postovit LM,Seftor EA,Lipavsky A.Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells..Proc Natl Acad Sci U S A2008;105:4329-34 PMCID:PMC2393795

[37] He N,Li Y,Xie X.Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer..Stem Cell Res Ther2016;7:95 PMCID:PMC4962384

[38] Dong W,Shen H,Du J.Antitumor effect of embryonic stem cells in a non-small cell lung cancer model: antitumor factors and immune responses..Int J Med Sci2013;10:1314-20 PMCID:PMC3752719

[39] Giuffrida D,Nagy A,Brown TJ.Human embryonic stem cells secrete soluble factors that inhibit cancer cell growth..Cell Prolif2009;42:788-98

[40] Gerecht S,Ferreira LS,Langer R.Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells..Proc Natl Acad Sci2007;104:11298-303 PMCID:PMC2040893

[41] Siti-Ismail N,Polak JM.The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance..Biomaterials2008;29:3946-52

[42] Wang W,Xie Y,Yu W.Microencapsulation using natural polysaccharides for drug delivery and cell implantation..J Mater Chem2006;16:3252-67

[43] Li Z,Hopper R,Zhang M.Feeder-free self-renewal of human embryonic stem cells in 3D porous natural polymer scaffolds..Biomaterials2010;31:404-12

[44] Watson AL,Moriarity BS,Conboy CB.Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance..Cancer Discovery2013;3:674-89 PMCID:PMC3679355

[45] Hazan RB.The epidermal growth factor receptor modulates the Interaction of E-cadherin with the actin cytoskeleton..J Biol Chem1998;273:9078-84

[46] Mangelberger D,Loipetzberger A,Aberger F.Cooperative Hedgehog-EGFR signaling..Front biosci (Landmark Ed)2012;17:90-9 PMCID:PMC3284771

[47] Lim SO,Xia W,Chang SS.EGFR signaling enhances aerobic glycolysis in triple-negative breast cancer cells to promote tumor growth and immune escape..Cancer Res2016;76:1284-96 PMCID:PMC4775355

[48] Takebe N,Ivy SP.Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition..Breast Cancer Res2011;13:211 PMCID:PMC3218933

[49] Maltseva DV,Fedotov NN,Lebedev AE.High-throughput identification of reference genes for research and clinical RT-qPCR analysis of breast cancer samples..J Clin Bioinforma2013;3:13 PMCID:PMC3726509

[50] Jacquin MA,Zunino B,Meynet O.GAPDH binds to active Akt, leading to Bcl-xL increase and escape from caspase-independent cell death..Cell Death Differ2013;20:1043 PMCID:PMC3705596

[51] Luetteke NC.Transforming growth factor alpha: expression, regulation and biological action of its integral membrane precursor..Semin Canc Biol1990;1:265-75

[52] Geng F,Anderson RA,Andrews DW.Multiple post-translational modifications regulate E-cadherin transport during apoptosis..J Cell Sci2012;125:2615-25 PMCID:PMC3706076

[53] Fang D,Zheng Y,Meisenhelder J.Phosphorylation of B-catenin by AKT promotes B-catenin transcriptional activity..J Biol Chem2007;282:11221-29 PMCID:PMC1850976